UCB SA

Pharmaceuticals
Belgium
Executive 1Dr. Roch Doliveux, Executive Chairman; Chief Executive Officer | Executive Chairman; Chief Executive Officer
Executive 2Fabrice Enderlin, Executive Vice President; | President; ; Chief Operating Officer; Subsidiary O
Earnings Per Share Growth (%)-3.51%
Cost of Goods Sold (US$ Millions)$1,280
Current Liabilities (US$ Millions)$2,839
Total Assets (US$ Millions)$3,040
Long Term Debt (Millions)$2,123
Return on Equity4.32%
Revenue (US$ Millions)$4,044
Total Company Assets$12,335
Revenue Growth (%)-3.31%
Net Income (US$ Millions)$242
Earnings Per Share (US$)$1.34
Total Equity (US$ Millions)$6,080
Profit Margin (%)5.98%
Debt To Equity Ratio (%)0.35%
Inventories (Millions)$665